Clinical practice guidelines on the evidence‐based use of integrative therapies during and after breast cancer treatment
Clinical practice guidelines on the evidence‐based use of integrative therapies during and after breast cancer treatment is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Clinical practice guidelines on the evidence‐based use of integrative therapies during and after breast cancer treatment have?
Clinical practice guidelines on the evidence‐based use of integrative therapies during and after breast cancer treatment has 779 citations in the OpenAlex counts ScholarIQ stores.
When was Clinical practice guidelines on the evidence‐based use of integrative therapies during and after breast cancer treatment published?
Clinical practice guidelines on the evidence‐based use of integrative therapies during and after breast cancer treatment has 2017 year in the ScholarIQ index.
What is the open-access status of Clinical practice guidelines on the evidence‐based use of integrative therapies during and after breast cancer treatment?
Clinical practice guidelines on the evidence‐based use of integrative therapies during and after breast cancer treatment has diamond oa status in the ScholarIQ index.
What is the DOI of Clinical practice guidelines on the evidence‐based use of integrative therapies during and after breast cancer treatment?
The DOI for Clinical practice guidelines on the evidence‐based use of integrative therapies during and after breast cancer treatment is on the source record.
What is the PMID of Clinical practice guidelines on the evidence‐based use of integrative therapies during and after breast cancer treatment?
The PMID for Clinical practice guidelines on the evidence‐based use of integrative therapies during and after breast cancer treatment is on the source record.
What is the OpenAlex record for Clinical practice guidelines on the evidence‐based use of integrative therapies during and after breast cancer treatment?
The OpenAlex for Clinical practice guidelines on the evidence‐based use of integrative therapies during and after breast cancer treatment is on the source record.